Showing results (91-100 of 887) with videos related to

Sort By:
Pageof 89
Drugs in R&D|July 5, 2005
Hexyl aminolevulinate: 5-ALA hexylester, 5-ALA hexylesther, aminolevulinic acid hexyl ester, hexaminolevulinate, hexyl 5-aminolevulinate, P 1206
Drugs in R&D|January 17, 2004
Arformoterol: (R,R)-eformoterol, (R,R)-formoterol, arformoterol tartrate, eformoterol-sepracor, formoterol-sepracor, R,R-eformoterol, R,R-formoterol
Drugs in R&D|January 17, 2004
Ecraprost: AS 013, Circulase
Drugs in R&D|January 17, 2004
KMD 3213: KAD 3213, silodosin
Drugs in R&D|November 26, 2004
Phase II study of antineoplaston A10 and AS2-1 in children with recurrent and progressive multicentric glioma : a preliminary reportStanislaw R Burzynski, Robert A Weaver, Robert I Lewy, et al.
Drugs in R&D|November 26, 2004
Testosterone Undecanoate-Schering AG
Drugs in R&D|July 5, 2005
Lubiprostone: RU 0211, SPI 0211
Drugs in R&D|September 15, 2016
Safety of Mebendazole Use During Lactation: A Case Series ReportNour Karra, Rana Cohen, Maya Berlin, et al.
Drugs in R&D|June 25, 2017
Lipophilicity Influences Drug Binding to α1-Acid Glycoprotein F1/S Variants But Not to the A VariantKazuhiko Hanada
Drugs in R&D|June 4, 2017
A Dipeptidyl Peptidase-4 Inhibitor, Teneligliptin, Decreases Plasma Triglyceride-Rich Lipoprotein Remnants in Diabetic Patients with Chronic Kidney Disease Undergoing HemodialysisKoichiro Homma, Joe Yoshizawa, Yutaka Shiina, et al.
Pageof 89